Life - Most Recent

Pages

How did Robert Altman stay in business?

Dec 1, 2006
Host Mark Austin Thomas and Daily Variety managing editor Michael Speier look at why maverick director Robert Altman would have had a hard time breaking into today's Hollywood.
Posted In: Entertainment

Price tag for HIV meds: $620,000

Dec 1, 2006
The lifetime treatment cost for an AIDS patient has hit $620,000 — and that figure probably isn't going down anytime soon. Jason Paur reports.
Posted In: Health

Blame it on Mojitos

Nov 30, 2006
U.S. rum sales are on fire this year, and that's raised the stakes in the trademark dispute over a storied rum from Cuba. Janet Babin reports.

DOJ expected to loosen up on corporate fraud

Nov 30, 2006
An influential panel known as the Paulson Group issued a report today warning that U.S. markets are losing their competitive edge — but the pendulum may already be swinging the other way. Hillary Wicai explains.
Posted In: Crime, Wall Street

Versatile, practical and now fashionable . . .cork

Nov 30, 2006
Cork is starting to stop up the fashion, accessories and flooring markets. The natural material benefits producers and, as it turns out, the environment. Janet Babin reports.

Russo's faux pas

Nov 30, 2006
Patricia Russo says she won't learn French. Which wouldn't be a problem — except that Friday she becomes the only American CEO of a blue-chip French company. The Marketplace Players offer a lesson in cultural sensitivity. . .

Prescription for profits: Hand out pink slips

Nov 29, 2006
Pfizer has announced that it will slash 20 percent of its workforce. The company's plagued by an industry-wide problem, as drug reps find it harder and harder to get face time with doctors. Helen Palmer reports.
Posted In: Health

Bring Big Pharma to the table

Nov 29, 2006
Democrats want to use Medicare to negotiate lower drug prices for seniors. Republicans and drug companies say it'll amount to government price controls. Commentator Robert Reich says that's absurd.
Posted In: Health

Celebrex for kids?

Nov 29, 2006
An FDA commission today is expected to consider whether pain reliever Celebrex is suitable to treat juvenile rheumatoid arthritis. Steve Tripoli reports.
Posted In: Health

New standards for patently obvious?

Nov 28, 2006
A Supreme Court case featuring a patent dispute over gas pedals could take some of the fuel out of the current patent system. Janet Babin explains.
Posted In: Crime

Pages